TY - JOUR T1 - Review: prokinetics, histamine H<sub>2</sub> receptor antagonists, antimuscarinics, and proton pump inhibitors improve global symptoms in non-ulcer dyspepsia JF - Evidence Based Medicine JO - Evid Based Med SP - 79 LP - 79 DO - 10.1136/ebm.12.3.79 VL - 12 IS - 3 A2 - , Y1 - 2007/06/01 UR - http://ebm.bmj.com/content/12/3/79.abstract N2 - Moayyedi P, Soo S, Deeks J, et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;(4):CD001960.OpenUrlPubMed 
 
 Q In patients with non-ulcer dyspepsia (NUD), do antacids, histamine H2 receptor antagonists (H2RAs), proton pump inhibitors (PPIs), prokinetics (PROK), mucosal protecting agents (MPAs), and antimuscarinics improve symptoms? Clinical impact ratings GP/FP/Primary care ★★★★★★☆ Gastroenterology ★★★★★★★ Internal medicine ★★★★★★☆ Data sources: Medline (1966 to January 2006), CINAHL (1982 to January 2006), EMBASE/Excerpta Medica (1988 to January 2006), Cochrane Central Register of Controlled Trials (Cochrane Library, Issue 4, 2005), SIGLE, bibliographies of relevant studies, experts in the field, and pharmaceutical companies. Study selection and assessment: randomised controlled trials (RCTs) that compared antacids, H2RAs, PPIs, PROK, MPAs, or antimuscarinics with placebo or other drugs in patients with symptoms … ER -